Verastem Inc

VSTM NASDAQ Santé & Biotech États-Unis US92337C2035
4.10 $
4.06 %

Verastem Inc se concentre sur le développement et la commercialisation de médicaments pour le traitement des cancers, en particulier les cancers hématologiques.

Performance & Momentum

6 Months 55.77 %
1 Year 26.79 %
3 Years 56.98 %
5 Years 92.84 %

Similar stocks to Verastem Inc

Anantys Community

Be the first to share your analysis on Verastem Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases